Funded Grants

Sofia Gentile, a Master’s Student at University of Toronto, is investigating the role of immune cell activation in a rare and fatal neurodegenerative disease called progressive supranuclear palsy.

Lu Wang, a Doctoral Student at McGill University, aims to compare the predictive accuracy of family history and polygenetic risk score for multiple sclerosis.

Personalized Modeling and Optimization of Transcranial Temporal Interference Stimulation in Major Depressive Disorder

Amyotrophic Lateral Sclerosis (ALS) is a fatal disease that progressively destroys motor neurons, leading to paralysis and death, with no current cure.

Jenna Hanrahan, a Doctoral Student at Memorial University of Newfoundland, aims to characterize the brain of a humanized mouse model of Huntington’s disease.

Amyotrophic Lateral Sclerosis (ALS) and frontotemporal dementia (FTD) are devastating diseases in which a protein called TDP-43 ends up in the wrong part of the cell, disrupting its normal role in managing RNA.

Amirhossein Jahani, a Postdoctoral Fellow at the University of Montreal, uses intracranial EEG to investigate how network interactions during the preictal phase (i.e., period preceding a seizure) may contribute to seizure initiation and propagation.

Timothy Friedman, a Postdoctoral Fellow at the University of British Columbia, is investigating the mechanisms through which DNA enables repair after injury in peripheral nerves but not the brain or spinal cord.

Amyotrophic Lateral Sclerosis (ALS) is a fatal disease that damages nerve cells controlling movement, and many patients also experience major changes in how their bodies use energy.

Contribution of stress-associated neurovascular alterations in Parkinson’s disease and high rates of depression